COMP <GO>
SRRK vs LLY // DIVIDEND YIELD & FCF PAYOUT SAFETY
Scholar Rock Holding Corporation (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: SRRK 2
— LLY 12
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: LLY
LAST: $43.90 (-0.63%) • MKT CAP: $5.38B
dividend-safety
0.00%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
dividend-safety
0.49%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRRK VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SRRK | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.00% | 83.64% | -39.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 32.36% | -67.36 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.59% | 2.30% | -7.89 | LLY | /fcf-yield <GO> |
| Operating Margin | 16.50% | 40.21% | -23.71 | LLY | /operating-margins <GO> |
| Net Profit Margin | 12.40% | 31.90% | -19.50 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 7.70% | 45.51% | -37.81 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 13.67 | 9.29 | +4.38 | SRRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.77% | +0.23 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.2 | 77.9 | -28.64 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.51 | +0.51 | SRRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 26.3x | +5.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.38B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SRRK REV | LLY REV | SRRK GROSS % | LLY GROSS % | SRRK FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $65.18B | — | 83.0% | -$300.6M | $16.81B |
| FY 2024 | $0 | $45.04B | — | 81.3% | -$201.0M | $8.82B |
| FY 2023 | $0 | $34.12B | — | 79.3% | -$145.2M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRRK // BETA 1.02
LLY // BETA 0.51